Eastman ChemicalEMN
EMN logo
Fair Value
US$84.33
Share price16 Jun
US$68.8618.3% undervalued intrinsic discount
Loading
1Y-13.46%
7D-2.62%

Commodity End Markets And Recycling Initiatives Will Shape Recovery Prospects Ahead

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
22 Aug 24
Updated
16 Jun 26
Views
449
Not Invested

Last Update 16 Jun 26

EMN: Recycling Investments And Cost Discipline Will Support Future Cash Flow Upside

Analysts have nudged the fair value estimate for Eastman Chemical higher to reflect a series of recent price target increases, including moves of $2 to $10 from multiple firms, citing updated views on the discount rate, revenue growth, profit margin and forward P/E assumptions.

Analyst Commentary

Recent Street research around Eastman Chemical clusters around a series of price target changes and one rating upgrade, giving you a snapshot of how professionals are framing the risk and reward trade off after revisiting their models.

Bullish Takeaways

  • Bullish analysts raising price targets by amounts ranging from US$2 to US$10 are signaling that, based on their assumptions, Eastman Chemical stock screens as more attractive than before on a risk adjusted basis.
  • Several price target moves reference adjustments to discount rate and forward P/E assumptions. This suggests these analysts are more comfortable with the company’s earnings profile and the valuation multiple they apply to those earnings.
  • The recent upgrade at JPMorgan indicates growing confidence in Eastman Chemical’s ability to execute on its plans. These analysts see this as supporting their revised fair value work.
  • Repeated upward target revisions in a relatively tight window point to a more constructive view on revenue and margin assumptions, which feeds directly into higher modeled cash flows and valuation output.

Bearish Takeaways

  • One bearish analyst trimming the price target by US$1 shows that not all firms share the same optimism, and some still see constraints on upside relative to their prior expectations.
  • The presence of both higher and slightly lower targets highlights that execution risks around revenue growth and margins remain part of the debate, even as many models move higher.
  • Differences in how analysts set discount rates and P/E multiples underscore that there is no single view on Eastman Chemical’s appropriate valuation. This can limit how much conviction some investors may place on the upper end of target ranges.
  • The modest target reduction amid a broader series of upgrades signals that some bearish analysts are emphasizing caution on future operating performance or capital allocation, even as the overall tone of research skews more constructive.

What’s in the News for Eastman Chemical

  • Eastman Chemical introduced Saflex Evoca XIR.SR, a next generation infrared reflective interlayer designed for electric vehicle sunroofs, aimed at reducing solar heat gain and supporting cabin comfort. (Source: Key Developments)
  • The Saflex Evoca XIR.SR interlayer is described as a high performance solar control alternative to metal coated glass, with a neutral, angle stable reflected color intended to preserve optical clarity and design flexibility across glass configurations. (Source: Key Developments)
  • Eastman Chemical highlighted potential efficiency benefits from Saflex Evoca XIR.SR, with lower total solar energy transmittance that can ease HVAC load and support battery and range efficiency, noting that actual range impact varies with driving profile, climate and usage. (Source: Key Developments)
  • The company indicated manufacturing and supply chain advantages for automotive glass suppliers, positioning Saflex Evoca XIR.SR as an option where metal coated glass is not feasible while still meeting OEM requirements. (Source: Key Developments)
  • Eastman Chemical plans to exhibit Saflex Evoca XIR.SR and the broader Saflex Evoca portfolio at the Beijing International Automotive Exhibition scheduled for April 24 to May 3, 2026. (Source: Key Developments)

Valuation Changes for Eastman Chemical

  • Fair Value: The modeled fair value for Eastman Chemical stock is unchanged at $84.33 per share, reflecting stable assumptions overall in the latest update.
  • Discount Rate: The discount rate has fallen slightly from 8.33% to 8.29%, indicating a modest reduction in the required return used in the valuation model.
  • Revenue Growth: Modeled long term revenue growth is essentially unchanged at 3.52%, with only a minimal numerical adjustment in the latest inputs.
  • Net Profit Margin: The projected net profit margin remains effectively stable at 9.08%, with only a very small recalibration in the model.
  • Future P/E: The assumed future P/E multiple is marginally lower, easing from 13.80x to 13.78x, reflecting a slightly more restrained valuation input.
6 viewsusers have viewed this narrative update

Key Takeaways

  • Expanding molecular recycling and specialty materials positions Eastman for growth as regulatory and consumer demand for sustainability strengthens across key markets.
  • Innovation, cost control, and supply chain reliability support margin expansion and predictable growth amid shifting environmental trends and global megatrends.
  • Trade tensions, weak demand, slow adoption of new products, regional concentration, and financial pressures threaten margins, growth prospects, and operational flexibility.

Catalysts

About Eastman Chemical
    Operates as a specialty materials company in the United States, China, and internationally.
What are the underlying business or industry changes driving this perspective?
  • Eastman's ongoing success and expansion in molecular recycling/methanolysis (including debottlenecking at Kingsport and operational improvements) positions the company to capture premium pricing and win volume as regulations and customer demand for recycled content accelerate, particularly as mechanical recycling underperforms in key end markets-driving sustained revenue growth and EBITDA margin expansion.
  • Growth in sustainable, advanced materials (i.e., specialty plastics/polymers for packaging, automotive, and consumer goods), supported by stable long-term contracts with global consumer brands (e.g., Pepsi, Unilever), is likely to drive predictable volume growth and improved top-line stability as emerging market consumption rises and regulatory requirements for recycled content strengthen.
  • Accelerating adoption of lighter, more efficient materials for automotive (electrification, lightweighting) and electronics-sectors where Eastman's specialty polymers are critical-should result in robust demand, supporting revenue and margin growth in the company's high-value segments as global megatrends in mobility and electronics persist.
  • Implementation of cost reduction initiatives ($75M-$100M in ongoing savings), strategic asset optimization (such as the ethylene to propylene project), and disciplined portfolio management is likely to lead to improving net margins and higher ROIC, especially as end-market demand recovers and utilization rates normalize.
  • Continued differentiation through innovation leadership (advanced recycling and specialty materials) and supply chain reliability (North American manufacturing base) positions Eastman as a preferred partner amid tightening environmental regulation and supply chain localization, supporting margin resilience and reducing earnings volatility.
Eastman Chemical Earnings and Revenue Growth

Eastman Chemical Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Eastman Chemical's revenue will grow by 3.5% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 4.6% today to 9.1% in 3 years time.
  • Analysts expect earnings to reach $870.3 million (and earnings per share of $7.65) by about June 2029, up from $399.0 million today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.9x on those 2029 earnings, down from 21.6x today. This future PE is lower than the current PE for the US Chemicals industry at 28.8x.
  • Analysts expect the number of shares outstanding to decline by 0.42% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.29%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Ongoing global trade tensions, high tariffs (15%–40%), and overcapacity/dumping from low-cost producers-particularly China-pose persistent risks to end-market demand, price realization, and market share, potentially leading to margin compression and suppressing revenue growth over the long term.
  • Uncertainty and volatility in customer demand, especially in key segments like consumer durables, automotive, and building & construction-driven by trade wars, inflation, and shifting inventory behaviors-may result in prolonged volume weakness and underutilization of assets, negatively impacting earnings and operating leverage.
  • Slower-than-expected adoption of innovative and recycled products (such as methanolysis-based Renew) due to customer economic caution, delayed project launches, and reliance on grant-related funding for expansion could limit top-line growth in high-value sustainable segments and stall improvements in EBITDA margins.
  • Elevated geographic dependence on US-based manufacturing and North American/European sales increases vulnerability to slowing regional GDP growth, retaliation in global trade disputes, and disruption of complex international supply chains, which could constrain revenue diversity and increase earnings volatility.
  • Overhang from recent capital-intensive investments, deferral of key growth projects, and the need for continued aggressive cost-cutting may restrict financial flexibility and cash flows, limiting capacity for R&D, innovation, and potential future shareholder returns, while higher interest expenses in a rising rate environment could erode net income.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $84.33 for Eastman Chemical based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $100.0, and the most bearish reporting a price target of just $74.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $9.6 billion, earnings will come to $870.3 million, and it would be trading on a PE ratio of 13.9x, assuming you use a discount rate of 8.3%.
  • Given the current share price of $75.28, the analyst price target of $84.33 is 10.7% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Eastman Chemical?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

US$67.68
FV
1.7% overvalued intrinsic discount
9.52%
Revenue growth p.a.
64
users have viewed this narrative
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Fair Value vs Share Price

US$84.33
vs US$68.8618.3% undervalued intrinsic discount
PastFuture011b2015201820212024202620272029Revenue US$9.6bEarnings US$870.3m
3.5%
Revenue growth
9.1%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Eastman Chemical

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Very undervalued established dividend payer.

Market capUS$7.9b
PB1.3x
Estimated Growth2.9%
Dividend Yield4.9%
Full analysis

CEO & management

Mark Costa
CEO
4.8yrs
CEO Tenure

Operates as a specialty materials company in the United States, China, and internationally.